A personalized treatment plan recommendation method and system based on artificial intelligence

CN118280512BActive Publication Date: 2025-01-17TAIHAOLE BIOTECHNOLOGY CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410403998.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-05
Publication Date
2025-01-17
Estimated Expiration
2044-04-05

Smart Images

  • Figure CN118280512B_ABST
    Figure CN118280512B_ABST
Patent Text Reader

Abstract

The present invention provides a personalized treatment plan recommendation method and system based on artificial intelligence, which obtains patient disease data and patient basic data; uses a neural network to process the patient disease data to obtain therapeutic drugs, and screens the therapeutic drugs; obtains the dosage range of the therapeutic drugs according to the patient basic data; obtains rehabilitation indicators based on the patient disease data; uses the gray wolf optimization algorithm to optimize the dosage range based on the rehabilitation indicators, and obtains the patient's optimal medication dosage; determines the therapeutic drugs to be taken according to the disease suffered by the patient, and after screening the therapeutic drugs, obtains the dosage range of the therapeutic drugs and the rehabilitation indicators of the disease types respectively, and finally uses the gray wolf optimization algorithm to calculate the optimal medication dosage, so as to obtain the optimal dosage of the therapeutic drugs used to treat the patient's disease. Since the patient's own physical condition is taken into consideration, the absorption effect of the drugs can be guaranteed, and the normal progress of the disease treatment can be guaranteed.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Gamma knife radiotherapy reverse design planning method

    CN103949015A

  • Clinical intelligent decision-making platform

    CN110827951A